express
highli
abund
ebvinfect
cell
copi
per
infect
cell
nucleu
four
ebv
latenc
program
describ
distinct
set
express
protein
viral
rna
latenc
express
protein
latenc
true
latenc
program
latenc
default
program
express
latent
membran
protein
lmp
latenc
growth
program
express
ebnalead
protein
lp
ebna
viral
latenc
disrupt
varieti
cellular
activ
induc
switch
latent
lytic
replic
mediat
zebra
protein
major
compon
lytic
phase
ebv
dna
polymeras
earli
late
lytic
protein
selfassembl
ebv
capsid
requir
viral
capsid
antigen
vca
major
capsid
protein
major
surfac
membran
antigen
viral
entri
b
cell
mediat
bind
complement
receptor
possibl
receptor
trigger
endocytosi
entri
seem
addit
requir
bind
mhc
class
ii
initi
fusion
viral
endosom
membran
releas
viral
genet
materi
cell
role
ebv
protein
character
mainli
vitro
use
lymphoblastoid
cell
line
lcl
brief
critic
mainten
ebv
genom
cell
divis
import
growth
transform
modul
activ
may
role
regul
transcript
lmp
transmembran
protein
mimic
activ
receptor
necessari
transform
rest
b
cell
peopl
infect
ebv
preval
higher
lessdevelop
countri
infect
childhood
asymptomat
present
subtl
sign
symptom
howev
half
individu
infect
late
teen
typic
present
im
ebv
usual
transmit
via
oral
rout
replic
intens
oropharyng
epitheli
cell
viru
enter
lytic
program
infect
local
b
cell
b
cell
migrat
peripher
lymphoid
tissu
rare
b
cell
also
present
bloodstream
viru
evolv
strategi
render
host
immun
respons
unabl
elimin
infect
cell
enabl
viru
set
persist
infect
viru
keep
immunolog
silent
persist
infect
b
cell
turn
gene
rare
undergo
reactiv
infect
enter
latent
phase
malign
diseas
may
eman
chronic
infect
neoplasm
known
caus
ebv
burkitt
lymphoma
hodgkin
diseas
nasopharyng
carcinoma
posttranspl
lymphoprolif
disord
ptld
differ
type
malign
relat
differ
viru
program
instanc
burkitt
lymphoma
known
associ
latenc
programm
nasopharyng
carcinoma
hodgkin
lymphoma
latenc
programm
lymphoprolif
diseas
immunocompromis
patient
latenc
programm
wherea
hairi
oral
leukoplakia
relat
lytic
program
year
sever
autoimmun
diseas
multipl
sclerosi
ms
system
lupu
erythematosu
sle
rheumatoid
arthriti
ra
link
ebv
infect
ms
inflammatori
autoimmun
diseas
human
central
nervou
system
infecti
agent
plausibl
candid
trigger
perpetu
diseas
sever
virus
suggest
trigger
ms
consist
strength
associ
render
ebv
outstand
candid
similar
epidemiolog
ms
im
sever
studi
shown
individu
previou
histori
im
higher
risk
acquir
ms
metaanalysi
calcul
combin
rel
risk
ms
im
ci
p
besid
demonstr
potenti
role
ebv
ms
find
may
also
suggest
time
primari
ebv
infect
import
develop
ms
infect
adulthood
higher
risk
develop
ms
infect
childhood
highrisk
region
ms
first
encount
ebv
occur
puberti
mani
individu
larg
danish
studi
patient
im
observ
twofold
increas
risk
ms
im
cohort
ad
evid
associ
im
ms
addit
studi
risk
get
ms
augment
year
im
sever
studi
compar
presenc
common
ebv
antibodi
ms
patient
healthi
control
systemat
review
demonstr
nearli
ms
patient
infect
ebv
compar
healthi
individu
studi
report
odd
ratio
develop
ms
ci
ebvposit
individu
second
systemat
review
confirm
relat
ebv
seroposit
ms
calcul
odd
ratio
develop
ms
seroneg
individu
ci
moreov
anoth
studi
confirm
risk
ms
ebvneg
individu
low
howev
consider
increas
individu
infect
ebv
metaanalysi
casecontrol
studi
found
associ
ms
exposur
ebv
determin
antivca
igg
antibodi
longitudin
prospect
studi
blood
sampl
collect
prior
onset
ms
show
risk
develop
ms
strongli
associ
increas
level
ebv
antibodi
titer
prior
diseas
onset
strongest
associ
found
igg
evid
ebv
antibodi
might
marker
clinic
radiolog
diseas
activ
ms
shown
patient
clinic
relaps
compar
patient
clinic
remiss
evid
peripher
ebv
reactiv
document
increas
igm
iga
respons
ebv
ea
detect
ebv
dna
serum
moreov
patient
antiebv
ea
antibodi
gadolinium
gd
enhanc
lesion
magnet
reson
imag
mri
gdenhanc
lesion
also
shown
correl
igg
igg
ratio
addit
igg
titer
antivca
igg
level
correl
lesion
volum
chang
followup
igg
titer
predictor
chang
expand
disabl
statu
scale
edss
score
antivca
igg
level
posit
correl
lesion
volum
neg
correl
atrophi
paramet
gray
matter
fraction
gmf
brain
parenchym
fraction
bpf
increas
antivca
igg
level
associ
greater
decreas
bpf
year
studi
igg
neg
associ
gmf
associ
antiebv
ea
igg
antibodi
mri
paramet
measur
although
demonstr
ebv
viral
load
associ
overal
ms
risk
ebv
viral
load
associ
increas
diseas
activ
shown
patient
clinic
isol
syndrom
ci
immun
respons
igg
ebv
antigen
correl
baselin
number
lesion
number
lesion
meet
barkhof
criteria
baselin
number
lesion
followup
presenc
new
lesion
edss
score
followup
addit
increas
igg
respons
predict
convers
ms
base
mcdonald
criteria
howev
correl
found
ebv
igg
respons
number
gdenhanc
lesion
although
find
base
small
proport
studi
patient
contrari
studi
anoth
studi
fail
show
clinic
valu
serum
igg
level
associ
diseas
cours
clinic
diseas
activ
elev
ebvvca
antibodi
also
posit
associ
predispos
factor
ms
healthi
individu
includ
femal
gender
current
smoke
statu
total
number
packyear
smoke
high
ebv
titer
present
confer
risk
ms
consider
increas
one
studi
rel
risk
ms
increas
ninefold
femal
ms
patient
elev
titer
antibodi
impli
interact
two
risk
factor
compar
woman
low
titer
recent
studi
conclud
smoke
like
enhanc
associ
high
antiebna
titer
increas
risk
ms
conclus
ebv
seroposit
like
predispos
factor
develop
ms
howev
direct
caus
relat
ms
establish
ebv
seroposit
also
associ
autoimmun
diseas
might
indic
ebv
play
role
autoimmun
gener
possibl
differ
strain
ebv
differ
biolog
activ
may
associ
occurr
ms
put
forward
studi
investig
whether
ebv
strain
differ
ms
patient
healthi
individu
one
initi
studi
munch
et
al
use
sequenc
code
region
show
similar
number
repeat
eight
ms
patient
cluster
cohort
major
random
ms
patient
varieti
control
cohort
conclud
ms
patient
infect
subtyp
lindsey
et
al
howev
found
differ
sequenc
ms
patient
control
recent
brennan
et
al
found
sever
singl
nucleotid
polymorph
within
gene
one
within
gene
occur
margin
differ
frequenc
ebv
strain
isol
ms
patient
compar
control
variat
sequenc
n
c
terminu
also
detect
simon
et
al
ms
patient
compar
control
howev
longitudin
studi
sitkigreen
et
al
found
differ
ebv
strain
blood
oral
caviti
individu
indic
differ
strain
may
also
occur
host
also
sequenc
span
tcell
epitop
vari
strain
individu
may
therefor
harbor
viral
quasispeci
describ
human
immunodefici
viru
area
select
pressur
acquir
mutat
allow
escap
immun
surveil
contrast
result
strain
specif
ebv
ms
warrant
futur
studi
ebv
evolv
eleg
strategi
enabl
escap
immun
surveil
allow
viru
set
latent
viral
infect
thu
reactiv
infect
new
host
ebv
start
infecti
cycl
b
cell
via
bind
main
viral
envelop
glycoprotein
complement
receptor
ebv
infect
epitheli
cell
depend
assist
viral
glycoprotein
eg
appear
necessari
bind
fusion
ebv
mhc
class
ii
express
cell
latent
ebv
protein
express
infect
b
cell
mimic
activ
receptor
antigenactiv
bcell
receptor
bcr
play
role
activ
prolifer
matur
b
cell
persist
ebv
memori
b
cell
latent
infect
b
cell
ebv
virion
maintain
episom
form
keep
immunolog
silent
ebv
express
limit
repertoir
approxim
gene
downregul
surfac
express
mhc
class
ii
b
cell
viru
abl
transient
switch
lytic
phase
approxim
gene
express
encod
protein
build
virion
onward
transmiss
ebv
infect
close
control
ebvspecif
cell
percentag
b
cell
peripher
blood
healthi
individu
latent
infect
b
cell
within
peripher
blood
mononuclear
cell
yet
known
frequenc
similar
ms
patient
would
give
us
indic
whether
ebvspecif
tcell
respons
alter
circul
cytotox
cell
program
erad
infect
b
cell
upon
infect
antigenpres
cell
viral
protein
undergo
proteosom
degrad
result
peptid
transport
endosom
reticulum
load
onto
mhc
class
molecul
present
cell
surfac
circul
cytotox
cell
one
protein
pronounc
immunolog
interest
highli
immunogen
protein
express
sever
latenc
program
viru
contain
long
glycinealanin
repeat
sequenc
hinder
proteosom
degrad
enabl
escap
tcell
recognit
express
b
cell
tightli
control
kept
level
allow
mainten
viral
episom
high
enough
elicit
vigor
immun
respons
sever
studi
investig
ebvspecif
tcell
respons
ms
patient
sometim
paradox
result
initi
studi
analyz
ms
patient
healthi
control
increas
frequenc
cell
reactiv
two
five
one
ebv
epitop
found
ms
patient
followup
studi
seven
ebv
epitop
demonstr
differ
ms
patient
healthi
control
increas
frequenc
elicit
hla
class
irestrict
ebv
peptid
detect
peopl
ci
similar
frequenc
found
ms
patient
healthi
control
recent
studi
describ
increas
frequenc
cell
patient
ci
compar
healthi
control
although
frequenc
cell
specif
ebvderiv
immunodomin
tcell
epitop
differ
patient
control
studi
use
ebvinfect
bcell
lcl
express
latent
lytic
phase
protein
one
studi
report
decreas
tcell
respons
ebv
measur
elispot
lower
mean
frequenc
peripher
blood
mononuclear
cell
respons
autolog
lcl
ms
patient
compar
healthi
control
thelper
cell
orchestr
success
immun
respons
activ
tcell
function
induc
matur
b
cell
immunoglobulinproduc
plasma
cell
cell
recogn
exogen
antigen
present
mhc
class
ii
molecul
antigenpres
cell
studi
ms
patient
healthi
control
show
ms
patient
increas
tcell
respons
mainli
memori
phenotyp
panel
peptid
cover
entir
ctermin
region
recent
cohort
ci
patient
shown
almost
twice
frequenc
tcell
respons
elicit
overlap
librari
cterminu
peptid
healthi
ebv
carrier
interestingli
cell
ms
patient
control
also
react
myelin
peptid
ebv
encod
protein
interfer
mhc
class
ii
present
lytic
program
protein
function
ebv
dnase
downregul
surfac
express
mhc
class
mhc
class
ii
molecul
ebv
immediateearli
gene
act
inhibit
signal
also
caus
reduc
express
mhc
class
ii
molecul
surprisingli
intracellular
ebv
protein
express
b
cell
bypass
exogen
pathway
mhc
class
ii
pathway
consensu
yet
whether
ebvspecif
tcell
respons
decreas
increas
ms
patient
oppos
result
appear
stem
mainli
differ
experiment
setup
neuropatholog
studi
use
understand
drive
forc
neuroinflamm
also
essenti
confirm
refut
idea
virus
caus
ms
earli
patholog
studi
use
electron
microscopi
found
presenc
papovaviru
tubular
paramyxoviruslik
inclus
activ
ms
lesion
later
describ
parainfluenza
viru
type
inclus
soon
found
condit
later
interpret
organel
protein
artifact
newer
techniqu
situ
hybrid
polymeras
chain
reaction
pcr
allow
investig
virus
fail
demonstr
consist
presenc
measl
paramyxoviru
coronaviru
variou
member
herp
famili
varicella
zoster
viru
herp
simplex
viru
cytomegaloviru
also
found
ms
control
brain
demonstr
differ
viral
infect
ms
brain
led
hypothesi
may
singl
specif
underli
viral
trigger
ms
sever
common
viral
infect
may
play
role
patholog
cascad
earli
studi
fail
show
consist
presenc
ebv
within
ms
brain
hilton
et
al
find
ebv
cohort
ms
patient
includ
acut
chronic
activ
chronic
inact
shadow
plaqu
use
situ
hybrid
eber
sander
et
al
found
ebv
ms
patient
control
activ
plaqu
inact
plaqu
use
pcr
suboptim
tissu
preserv
prevent
opsahl
kennedi
draw
conclus
presenc
ebv
ms
brain
recent
patholog
studi
fuel
yet
debat
involv
ebv
ms
serafini
et
al
report
presenc
ebvinfect
b
cell
plasma
cell
situ
hybrid
immunohistochemistri
brain
ms
case
present
inflammatori
neurolog
diseas
primari
cerebr
vascul
viral
enceph
mycot
mening
encephalopathi
unknown
origin
eight
ms
case
known
ectop
bcell
follicl
rich
bcellplasma
cell
infiltr
case
less
infiltr
forti
percent
b
cell
plasma
cell
posit
eber
highest
percentag
b
cell
ectop
follicl
note
case
promin
eberposit
cell
accumul
case
rich
b
cellsplasma
cell
infiltr
ectop
bcell
follicl
less
infiltr
case
fewer
often
isol
eberposit
cell
viral
reactiv
demonstr
express
restrict
ectop
follicl
activ
lesion
studi
made
differ
observ
willi
et
al
examin
paraffinembed
formalinfix
tissu
specimen
ms
patient
select
sampl
bcell
infiltr
use
wide
rang
techniqu
includ
quantit
realtim
pcr
detect
genom
ebv
rna
situ
hybrid
eber
immunohistochemistri
addit
specimen
examin
aggreg
bcell
infiltr
within
mening
found
either
absent
low
case
bcell
aggreg
within
brain
parenchyma
realtim
pcr
detect
lowlevel
ebv
infect
two
case
ebv
undetect
situ
hybrid
peferoen
et
al
undertook
studi
screen
specimen
ms
patient
includ
patient
die
age
addit
studi
block
use
serafini
studi
sixteen
patient
accumul
bcell
infiltr
although
folliclelik
structur
present
specimen
realtim
pcr
ebv
dna
encod
rna
neg
tissu
examin
eber
detect
one
tissu
sampl
situ
hybrid
also
show
lytic
cycl
marker
anoth
studi
screen
activ
ms
lesion
overexpress
presenc
ebv
infect
situ
hybrid
probe
show
ebvposit
cell
white
matter
area
ms
lesion
one
case
acut
dissemin
encephalomyel
adem
author
propos
ebv
infect
may
play
indirect
role
via
accumul
ebvinfect
b
cell
area
initi
inflamm
stress
may
releas
viral
compon
eg
eber
bind
tolllik
receptor
thu
activ
innat
immun
respons
contribut
sustain
increas
inflamm
recent
studi
use
nest
nonnest
realtim
pcr
detect
ebvspecif
cellspecif
transcript
formalinfix
paraffinembed
freshfrozen
ms
plaqu
singl
cerebrospin
fluid
b
lymphocyt
plasma
cell
reveal
evid
activ
ebv
infect
studi
would
appear
ebvposit
cell
detect
activ
ms
lesion
far
less
frequent
report
time
howev
presenc
ebvposit
cell
may
specif
ms
brain
role
ebv
ms
pathogenesi
remain
unknown
present
studi
need
elucid
role
ebv
multifactori
diseas
potenti
contribut
neuroinflamm
guilt
infer
sole
associ
ebv
kept
close
observ
